CytoScan® Dx Assay
The first and only FDA-cleared whole-genome test to aid in the diagnosis of developmental delay*
Axiom® Biobank Genotyping Solution
The power of discovery is in the design.
Automated. Customizable. Cost-effective.
Axiom® Genotyping Solution for agrigenomics
The new OncoScan® FFPE Assay Kit
Delivering genome-wide copy number
in 48 hours.
GeneChip® Human Transcriptome Array 2.0 (HTA) delivers
More transcript isoforms. Higher accuracy and higher precision than 2 full lanes of sequencing data.
From RNA to biology within a week.
Educational resources and best practice for research and commercial agrigenomics.
Educational resources for the cancer community along with best practices and workflows.
Human Genotyping Community
Educational resources and facilitating the sharing of best practices and workflows.
eBioscience, now an Affymetrix company, is a world leader in immunology and oncology flow cytometry reagents for both Life Science research and diagnostics.
Affymetrix microarray solutions include all necessary components for a microarray experiment, from arrays and reagents to instruments and software.
The QuantiGene® product line is based on branched DNA (bDNA) technology, which delivers quantitative genetic analysis of unparalleled quality.
Links to the most current technical documentation for all Affymetrix products.
Affymetrix to Report Fourth Quarter and Fiscal Year 2014 Operating Results on Wednesday February 4, 2015
Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue of Approximately $93 Million and the Appointment of Merilee Raines to the Board of Directors
Affymetrix Expands Portfolio of Axiom Genotyping Arrays For Agrigenomics with New Offerings for Porcine and Equine Studies
- Affymetrix Chairman and Founder to Retire from Board of Directors
- Affymetrix to Report Fourth Quarter and Fiscal Year 2014 Operating Results on Wednesday February 4, 2015
- Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue of Approximately $93 Million and the Appointment of Merilee Raines to the Board of Directors